Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction.
Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction.
复制标题
DOI：
10.1371/journal.pone.0008443
复制
发表时间：
2009-12-31
期刊：
影响因子：
3.7
通讯作者：
Wu JC
中科院分区：
文献类型：
--
作者：
Li Z;Wilson KD;Smith B;Kraft DL;Jia F;Huang M;Xie X;Robbins RC;Gambhir SS;Weissman IL;Wu JC
人胚胎干细胞分化为内皮细胞（hESC-ECs）具有通过支持血管生成和血管生成为缺血性疾病的新型移植治疗提供无限细胞来源的潜力。然而，传统的拟胚体（EB）法的内皮分化效率较低，而与小鼠胚胎成纤维细胞（MEFs）共培养的二维方法需要动物源性材料，这两种方法都限制了hESC-ECs的临床应用。此外，为了充分了解干细胞治疗的有益效果，研究人员必须能够随着时间的推移跟踪活体移植细胞的功能生物学和生理学。在这项研究中，我们开发了一种细胞外基质（ECM）培养系统，以增加内皮细胞分化和无污染的动物细胞。我们使用全基因组芯片研究了hESC内皮分化过程中发生的转录变化，并与人脐静脉内皮细胞（HUVECs）进行了比较。我们还在小鼠背窗模型中显示了hESC-EC的功能性血管形成。此外，我们的研究是迄今为止第一个在心肌梗死模型中移植hESC-ECs并使用分子成像方法监测细胞命运的研究。总之，我们报告了一种更有效的方法，用于衍生hESC-ECs，表达适当的内皮基因模式，在体内形成功能性血管，并改善心脏功能。这些研究表明，hESC-ECs可能为缺血性心脏病提供一种新的治疗方法。
Differentiation of human embryonic stem cells into endothelial cells (hESC-ECs) has the potential to provide an unlimited source of cells for novel transplantation therapies of ischemic diseases by supporting angiogenesis and vasculogenesis. However, the endothelial differentiation efficiency of the conventional embryoid body (EB) method is low while the 2-dimensional method of co-culturing with mouse embryonic fibroblasts (MEFs) require animal product, both of which can limit the future clinical application of hESC-ECs. Moreover, to fully understand the beneficial effects of stem cell therapy, investigators must be able to track the functional biology and physiology of transplanted cells in living subjects over time. In this study, we developed an extracellular matrix (ECM) culture system for increasing endothelial differentiation and free from contaminating animal cells. We investigated the transcriptional changes that occur during endothelial differentiation of hESCs using whole genome microarray, and compared to human umbilical vein endothelial cells (HUVECs). We also showed functional vascular formation by hESC-ECs in a mouse dorsal window model. Moreover, our study is the first so far to transplant hESC-ECs in a myocardial infarction model and monitor cell fate using molecular imaging methods. Taken together, we report a more efficient method for derivation of hESC-ECs that express appropriate patterns of endothelial genes, form functional vessels in vivo, and improve cardiac function. These studies suggest that hESC-ECs may provide a novel therapy for ischemic heart disease in the future.
登录
查看更多内容
影响因子：
24
作者：
Li, Zongjin;Lee, Andrew;Huang, Mei;Chun, Hyung;Chung, Jaehoon;Chu, Pauline;Hoyt, Grant;Yang, Phillip;Rosenberg, Jarrett;Robbins, Robert C.;Wu, Joseph C.
通讯作者：
Wu, Joseph C.
影响因子：
56.9
作者：
Asahara, T;Murohara, T;Isner, JM
通讯作者：
Isner, JM
影响因子：
5.2
作者：
Li, Zongjin;Suzuki, Yoriyasu;Wu, Joseph C.
通讯作者：
Wu, Joseph C.
影响因子：
82.9
作者：
Kocher, AA;Schuster, MD;Itescu, S
通讯作者：
Itescu, S
影响因子：
37.8
作者：
Li, Zongjin;Wu, Jenny C.;Wu, Joseph C.
通讯作者：
Wu, Joseph C.